Prominent Players - Malaria Vaccines Industry

Feb, 2023 - by CMI

Prominent Players - Malaria Vaccines Industry

 

Over the forecast period, rising government attempts to combat malaria are anticipated to fuel market expansion for malaria vaccines worldwide. For instance, in October 2021, the World Health Organization (WHO) advised that children in sub-Saharan Africa and other areas with moderate to high P. falciparum malaria transmission widely use the RTS,S/AS01 (RTS,S) malaria vaccine. The advice was based on the outcomes of a trial programme that has been running in Ghana, Kenya, and Malawi and has helped more than 900,000 kids since 2019.

Global Malaria Vaccines Market is estimated to be valued at US$ 41.08 million in 2022 and is expected to exhibit a CAGR of 29.6% during the forecast period (2022-2030).

Top Companies in the Malaria Vaccines Industry:

1. GlaxoSmithKline plc

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. GSK plc and Wave Life Sciences Ltd in December, 2022 announced a strategic collaboration to advance oligonucleotide therapeutics, including Wave’s preclinical RNA editing programme targeting alpha-1 antitrypsin deficiency (AATD), WVE-006.

2. Nobelpharma

Nobelpharma was founded in 2003 and projects of drugs and medical devices for unmet medical needs. It has headquarters situated in Chuo-ku, Tokyo. In February, 2023 Nobelpharma announced that the company has launched NOBELZIN® Granules 5% for Wilson's disease (copper absorption inhibitor) and hypozincemia.

3. CellFree Sciences

CellFree Sciences was established in 2002. It has headquarters situated in Ehime, Japan.

4. VLP Therapeutics LLC

VLP Therapeutics, LLC (VLP) was established in 2013 by seasoned biopharmaceutical veterans with mission to develop innovative medical treatment which transforms traditional vaccine and targeted antibody therapies to address global unmet medical needs. The company is headquartered in Gaithersburg, Maryland. In October, 2020 VLP Therapeutics Japan, LLC (VLPTJ) announced that VLPTJ signed a contract manufacturing agreement with FUJIFILM Corporation (FUJIFILM) for a novel coronavirus (COVID-19) vaccine formulation developed by VLPTJ.

5. Sumaya Biotech

Sumaya Biotech was spun off from Heidelberg University in 2014.It has headquarters situated in Heidelberg, Germany.

6. BioNTech

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany. In February, 2023 announced construction completion of the Company’s first proprietary plasmid DNA manufacturing facility in Marburg, Germany.

7. Precigen, Inc.

Precigen, Inc. discovers and develops the next generation of gene and cellular therapies. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.

*Definition- Malaria vaccines are treatments that provide defence against the infectious disease termed malaria that is spread by mosquitoes.

 

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.